DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kosiborod M, Cavender MA, Fu AZ. et al.
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose
Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL
Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of
Sodium-Glucose Cotransporter-2 Inhibitors).
Circulation 2017;
136: 249-259
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.